## **Core Concept**
β-thalassemia is a genetic disorder affecting hemoglobin synthesis, characterized by reduced or absent production of the β-globin subunit of hemoglobin. This condition leads to various degrees of anemia, depending on the specific mutation and its impact on β-globin production. The disorder is inherited in an autosomal recessive pattern.

## **Why the Correct Answer is Right**
The correct answer involves understanding the pathophysiology of β-thalassemia. In β-thalassemia, there is a **reduced synthesis** of the β-globin chains of hemoglobin due to mutations in the HBB gene. This results in an imbalance between α and β globin chains, leading to ineffective erythropoiesis and hemolysis. The specific nature of the mutation (e.g., missense, nonsense, frameshift) influences the severity of the disease, which can range from β-thalassemia minor (mild) to β-thalassemia major (severe).

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because β-thalassemia is not primarily characterized by an increased synthesis of β-globin chains; rather, it's the opposite.
- **Option B:** This option is incorrect as β-thalassemia major, also known as Cooley's anemia, is a severe form of the disease but specifying "increased" synthesis is inaccurate.
- **Option C:** Not directly provided but assuming it suggests normal synthesis or another incorrect mechanism, it would be wrong because β-thalassemia involves a defect in β-globin synthesis.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that β-thalassemia major requires regular blood transfusions and iron chelation therapy to manage complications like iron overload. The diagnosis involves genetic testing to identify specific mutations and assessing the severity of the disease.

## **Correct Answer:** .